Third View Private Wealth, LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 2083406 WESTPORT, CT

Position in LGND

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$242,441

New position

Shares Held

767

first reported quarter

Ownership

0.004%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#295

of 411 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Third View Private Wealth, LLC holds $14,122,174 across 3 Biotechnology names. LGND ranks #3 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	17,866	$8,874,578
2	REGN	Regeneron Pharmaceuticals, Inc.	8,027	$5,005,155
3	LGND	Ligand Pharmaceuticals Inc This page	767	$242,441

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$242,441	767	—	Shares	Other	2026-07-27
No filing history on record for this holder in this stock.